Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants

Vaccine

Volumn 30, Issue SUPPL. 1, 2012, Pages

  Laserson, Kayla F ^a,b   Nyakundi, Daveline ^a   Feikin, Daniel R ^a,b   Nyambane, Geoffrey ^a   Cook, Earnest ^a   Oyieko, Janet ^a   Ojwando, Joel ^a   Rivers, Stephen B ^c   Ciarlet, Max ^c   Neuzil, Kathleen M ^d   Breiman, Robert F ^a,b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d PATH   (United States)

Author keywords

Adverse events; HIV; Intussusception; Pentavalent rotavirus vaccine; RotaTeq ; Rotavirus; Safety; Serious adverse events

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE;

ABDOMINAL PAIN; ANEMIA; ARTICLE; BODY TEMPERATURE; BRONCHIOLITIS; BRONCHOPNEUMONIA; BRONCHOSPASM; CAUSE OF DEATH; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG EXPOSURE; DRUG FATALITY; DRUG SAFETY; DYSPNEA; FEBRILE INFECTION; FEMALE; FEVER; FOLLOW UP; GASTROENTERITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFANT; INFECTION; INJURY; INTOXICATION; INTUSSUSCEPTION; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDIASTINAL DISORDER; MENINGITIS; MORTALITY; NUTRITIONAL STATUS; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PNEUMONIA ASPIRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RHINITIS; RHINORRHEA; RISK ASSESSMENT; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN ALLERGY; THORACIC DISORDER; THRUSH; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VOMITING;

ADMINISTRATION, ORAL; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; GASTROENTERITIS; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INTUSSUSCEPTION; KENYA; MALE; PLACEBOS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINES, ATTENUATED;

EID: 84859974575     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.026     Document Type: Article

References (32)

1. WHO Rotavirus vaccines. Wkly Epidemiol Rec 2007, 82:285-296.
2. Parashar U.D., Hummelmann E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis J 2003, 9:565-572.
3. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(Suppl. 1):S9-S15.
4. Van Eijk A.M., Brooks J.T., Adcock P.M., Garrett V., Eberhard M., Rosen D.H., et al. Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya. Int J Infect Dis 2010, e220-e225.
5. Thea D.M., St Louis M.E., Atido U., Kanjinga K., Kembo B., Matondo M., et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med 1993, 329:1696-1702.
6. Pavia A.T., Long E.G., Ryder R.W., Nsa W., Puhr N.D., Wells J.G., et al. Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic, and epidemiologic features. Pediatr Infect Dis J 1992, 11:996-1003.
7. Kiulia N.M., Nyaundi J.K., Peenze I., Nyachieo A., Musoke R.N., Steele A.D., et al. Rotavirus infections among HIV-infected children in Nairobi, Kenya. J Trop Pediatr 2009, 5:318-323.
8. CDC Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999, 48:577-581.
9. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Eng J Med 2001, 344:564-572.
10. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriquez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med 2006, 354:23-33.
11. Ward R.L., Bernstein D.I. Rotarix: a rotavirus vaccine for the world. CID 2009, 48:222-228.
12. Vesikari T., Itzler R., Matson D.O., Santosham M., Christie C., Coia M., et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis 2007, 11:S29-S35.
13. Ciarlet M., Schodel F. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq®. Vaccine 2009, 27:G72-G81.
14. Armah G., Sow S., Breiman R., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomized, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
15. Zaman K., Anh D.D., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
16. National AIDS/STI Control Program (NASCOP), Kenya. 2007 Kenya AIDS Indicator Survey: Final Report. Nairobi, NASCOP, September 2009.
17. KEMRI/CDC Research and Public Health ollaboration. KEMRI/CDC Health and Demographic Surveillance System, 2008 Annual Report. KEMRI/CDC Research and Public Health Collaboration, Kisumu, Kenya, pp. 1-36.
18. Kenya National Bureau of Statistics (KNBS) and ICF Macro. 2010. Kenya Demographic and Health Survey 2008-09. Calverton, Maryland: KNBS and ICF Macro.
19. Bines J.E., Kohl K.S., Forster J., Zanardi L.R., Davis R.L., Hansen J., et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004, 22:569-574.
20. WHO Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009, 84(December (51-52)):533-540.
21. Merck & Co., Inc. Protocol V260-015-04. Efficacy, Safety and Immunogenicity of RotaTeq® Among Infants in Asia and Africa, 2008.
22. Huppertz H., Salman N., Giaquinto C. Risk factors for severe rotavirus gastroenteritis. Pediatr Infect Dis J 2008, 27:S11-S19.
23. Steele A.D., Cunliffe N., Tumbo J., Madhi S.A., De Vos B., Bouckenooghe A. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis 2009, 200(Suppl. 1):S57-S62.
24. Cunliffe N.A., Gondwe J.S., Kirkwood C.D., Graham S.M., Nhlane N.M., Thindwa B., et al. Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 2001, 358:550-555.
25. Liste M.B., Natera I., Suarez J.A., Pujol F.H., Liprandi F., Ludert J.E. Enteric virus infections and diarrhea in healthy and HIV-infected children. J Clin Microbiol 2000, 38:2873-2877.
26. Oshitani H., Kasolo F.C., Mpabalwani M., Luo N.P., Matsubayashi N., Bhat G.H., et al. Association of rotavirus and HIV infection in children hospitalized with acute diarrhea, Lusaka, Zambia. J Infect Dis 1994, 169:897-900.
27. Kotloff K., Johnson J.P., Nair P., Hickman D., Lippincott P., Wilson P.D., et al. Diarrheal morbidity during the first 2 years of life among HIV-infected infants. JAMA 1994, 271:448-452.
28. WHO Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec 2010, 85(June):213-228.
29. CDC Prevention of rotavirus gastroenteritis among infants and children: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2009, 58:1-25.
30. Steele A.D., Madhi S.A., Louw C.E., Bos P., Tumbo J.M., Werner C.M., et al. Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa. Pediatr Infect Dis J 2011, 30:125-130.
31. NIAID. Safety and immune response of a rotavirus vaccine in HIV-infected and uninfected children born to HIV-infected mothers. Clin Trial: Currently recruiting. ctgov:NCT00880698.
32. Newell M.L., Coovadia H., Cortina-Borja M., Rollins N., Gaillard P., Dabis F., et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004, 364:1236-1243.